(Q35881841)

10 August 2017

0 references

The risk of breast cancer associated with oral contraception and hormone replacement therapy (English)

1 reference

10 August 2017

1 reference

L Speroff

1

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 January 1992

1 reference

10 August 2017

published in

Women's Health Issues

1 reference

10 August 2017

volume

2

1 reference

10 August 2017

issue

2

1 reference

10 August 2017

page(s)

63-72; discussion 73-4

1 reference

Oral contraceptives and breast cancer: final report of an epidemiological study

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1049-3867%2805%2980274-9

7 January 2021

Oral contraceptives and breast cancer: latest findings in a large cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1049-3867%2805%2980274-9

7 January 2021

Prospective study of oral contraceptive use and risk of breast cancer in women.

1 reference

https://api.crossref.org/works/10.1016%2FS1049-3867%2805%2980274-9

7 January 2021

Oral contraceptives and cancers of the breast and of the female genital tract. Interim results from a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1049-3867%2805%2980274-9

7 January 2021

Oral contraceptive use and breast cancer in young women. A joint national case-control study in Sweden and Norway

1 reference

https://api.crossref.org/works/10.1016%2FS1049-3867%2805%2980274-9

7 January 2021

Breast cancer and the pill--a further report from the Royal College of General Practitioners' oral contraception study

1 reference

https://api.crossref.org/works/10.1016%2FS1049-3867%2805%2980274-9

7 January 2021

Breast cancer before age 45 and oral contraceptive use: new findings.

1 reference

https://api.crossref.org/works/10.1016%2FS1049-3867%2805%2980274-9

7 January 2021

Breast cancer and combined oral contraceptives: results from a multinational study. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS1049-3867%2805%2980274-9

7 January 2021

A Case-Control Study of Oral Contraceptive Use and Breast Cancer23

1 reference

https://api.crossref.org/works/10.1016%2FS1049-3867%2805%2980274-9

7 January 2021

Breast cancer and oral contraceptive use

1 reference

https://api.crossref.org/works/10.1016%2FS1049-3867%2805%2980274-9

7 January 2021

Oral contraceptives and breast cancer in young women.

1 reference

https://api.crossref.org/works/10.1016%2FS1049-3867%2805%2980274-9

7 January 2021

Early oral contraceptive use and breast cancer: results of another case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1049-3867%2805%2980274-9

7 January 2021

Oral contraceptives and premenopausal breast cancer in nulliparous women

1 reference

https://api.crossref.org/works/10.1016%2FS1049-3867%2805%2980274-9

7 January 2021

Oral contraceptives and breast cancer: results from an expanded case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1049-3867%2805%2980274-9

7 January 2021

Oral contraceptives and breast cancer. A prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1049-3867%2805%2980274-9

7 January 2021

Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use

1 reference

https://api.crossref.org/works/10.1016%2FS1049-3867%2805%2980274-9

7 January 2021

Oral-contraceptive use and the risk of breast cancer. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development

1 reference

https://api.crossref.org/works/10.1016%2FS1049-3867%2805%2980274-9

7 January 2021

Oral contraceptive use in women with a family history of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1049-3867%2805%2980274-9

7 January 2021

Breast cancer risk in relation to type of estrogen contained in oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS1049-3867%2805%2980274-9

7 January 2021

Breast cancer in relation to early use of oral contraceptives. No evidence of a latent effect

1 reference

https://api.crossref.org/works/10.1016%2FS1049-3867%2805%2980274-9

7 January 2021

Oral contraceptive use and the risk of breast cancer in women with a "prior" history of benign breast disease

1 reference

https://api.crossref.org/works/10.1016%2FS1049-3867%2805%2980274-9

7 January 2021

The risk of breast cancer after estrogen and estrogen-progestin replacement

1 reference

https://api.crossref.org/works/10.1016%2FS1049-3867%2805%2980274-9

7 January 2021

Prognosis after breast cancer diagnosis in women exposed to estrogen and estrogen-progestogen replacement therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1049-3867%2805%2980274-9

7 January 2021

Mammographic parenchymal patterns in women receiving noncontraceptive estrogen treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1049-3867%2805%2980274-9

7 January 2021

Influence of non-contraceptive exogenous and endogenous sex hormones on breast cancer risk in Denmark.

1 reference

https://api.crossref.org/works/10.1016%2FS1049-3867%2805%2980274-9

7 January 2021

Menopausal oestrogens and breast cancer risk: an expanded case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1049-3867%2805%2980274-9

7 January 2021

Exogenous estrogen and breast cancer after bilateral oophorectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1049-3867%2805%2980274-9

7 January 2021

Menopausal Estrogens and Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1049-3867%2805%2980274-9

7 January 2021

Breast cancer and estrogen replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1049-3867%2805%2980274-9

7 January 2021

Replacement estrogens and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1049-3867%2805%2980274-9

7 January 2021

Exogenous estrogens and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1049-3867%2805%2980274-9

7 January 2021

A prospective cohort study of postmenopausal hormone use and risk of breast cancer in US women

1 reference

https://api.crossref.org/works/10.1016%2FS1049-3867%2805%2980274-9

7 January 2021

Non-contraceptive exogenous oestrogen therapy and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1049-3867%2805%2980274-9

7 January 2021

Influence of exogenous estrogens, proliferative breast disease, and other variables on breast cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS1049-3867%2805%2980274-9

7 January 2021

Oestrogen therapy after the menopause--boon or bane?

1 reference

https://api.crossref.org/works/10.1016%2FS1049-3867%2805%2980274-9

7 January 2021

A Meta-analysis of the Effect of Estrogen Replacement Therapy on the Risk of Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1049-3867%2805%2980274-9

7 January 2021

Estrogen Replacement Therapy II: A Prospective Study in the Relationship to Carcinoma and Cardiovascular and Metabolic Problems

1 reference

https://api.crossref.org/works/10.1016%2FS1049-3867%2805%2980274-9

7 January 2021

The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1049-3867%2805%2980274-9

7 January 2021

10.1016/S1049-3867(05)80274-9

Identifiers

DOI

1 reference

10 August 2017

1 reference